CS-2883 - Names and Identifiers
CS-2883 - Physico-chemical Properties
Molecular Formula | C16H17N5O2
|
Molar Mass | 311.34 |
Density | 1.48±0.1 g/cm3(Predicted) |
Boling Point | 559.8±60.0 °C(Predicted) |
pKa | 3.94±0.12(Predicted) |
Storage Condition | 2-8℃ |
CS-2883 - Preparation solution concentration reference
| 1mg | 5mg | 10mg |
---|
1 mM | 0 ml | 0 ml | 0 ml |
5 mM | 0 ml | 0 ml | 0 ml |
10 mM | 0 ml | 0 ml | 0 ml |
5 mM | 0 ml | 0 ml | 0 ml |
Last Update:2024-01-02 23:10:35
CS-2883 - Introduction
BI-409306 is a compound whose chemical name is 3-(4-cyclopropylpiperidin-1-yl)-5-methyl -1H-pyrazol-4-amine. The following is a description of the nature, use, preparation and safety information of the BI-409306:
Nature:
-Appearance: BI-409306 is white solid powder.
-Molecular formula: C15H19N5
-Molecular weight: 281.35g/mol
-Melting Point: 165-166 ℃
-Solubility: BI-409306 soluble in common organic solvents.
Use:
- BI-409306 is an inhibitor of the inflammation-related tyrosine kinase Akt. The Akt signaling pathway plays an important role in cell growth and survival, metabolic regulation and other biological processes. BI-409306 can inhibit the activation of the Akt pathway, which is expected to play a role in the treatment of inflammation-related diseases, such as inflammatory bowel disease and certain tumors.
Preparation Method:
-The BI-409306 synthesis method includes multiple steps. A common synthetic method is to synthesize the target compound from appropriate starting materials through an organic synthesis reaction.
Safety Information:
- BI-409306 safety and toxicity data may be limited, so further research and evaluation are needed. When using or handling BI-409306, follow laboratory safety practices and pay attention to appropriate protective equipment, such as gloves, goggles, and protective clothing. In case of misuse or contact with skin, eyes and other parts, wash immediately and seek medical assistance. Otherwise, the chemical supplier or relevant agency should be consulted for more detailed safety information.
Last Update:2024-04-10 22:29:15